- Home
- FFIC vs SVRA Comparison
FFIC vs SVRA Comparison
Compare FFIC & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FFIC
- SVRA
- Stock Information
- Founded
- FFIC 1929
- SVRA N/A
- Country
- FFIC United States
- SVRA United States
- Employees
- FFIC N/A
- SVRA N/A
- Industry
- FFIC Major Banks
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- FFIC Finance
- SVRA Health Care
- Exchange
- FFIC Nasdaq
- SVRA Nasdaq
- Market Cap
- FFIC 469.5M
- SVRA 458.2M
- IPO Year
- FFIC 1995
- SVRA N/A
- Fundamental
- Price
- FFIC $14.18
- SVRA $2.69
- Analyst Decision
- FFIC Hold
- SVRA Buy
- Analyst Count
- FFIC 4
- SVRA 7
- Target Price
- FFIC $15.50
- SVRA $9.86
- AVG Volume (30 Days)
- FFIC 275.2K
- SVRA 609.7K
- Earning Date
- FFIC 01-28-2025
- SVRA 03-06-2025
- Dividend Yield
- FFIC 6.02%
- SVRA N/A
- EPS Growth
- FFIC N/A
- SVRA N/A
- EPS
- FFIC N/A
- SVRA N/A
- Revenue
- FFIC $115,172,000.00
- SVRA N/A
- Revenue This Year
- FFIC N/A
- SVRA N/A
- Revenue Next Year
- FFIC $9.20
- SVRA N/A
- P/E Ratio
- FFIC N/A
- SVRA N/A
- Revenue Growth
- FFIC N/A
- SVRA N/A
- 52 Week Low
- FFIC $10.74
- SVRA $2.59
- 52 Week High
- FFIC $18.59
- SVRA $5.70
- Technical
- Relative Strength Index (RSI)
- FFIC 43.04
- SVRA 40.81
- Support Level
- FFIC $14.42
- SVRA $2.65
- Resistance Level
- FFIC $15.18
- SVRA $2.91
- Average True Range (ATR)
- FFIC 0.49
- SVRA 0.11
- MACD
- FFIC 0.03
- SVRA 0.01
- Stochastic Oscillator
- FFIC 44.75
- SVRA 23.08
About FFIC Flushing Financial Corporation
Flushing Financial Corp operates as a bank holding company, which is engaged in the provision of banking and financial services. It provides Personal, Business, lending, Government banking, and Card services. Its principal business is attracting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, in originations and purchases of multi-family residential properties, commercial business loans, commercial real estate mortgage loans, construction loans, small business administration loans, and other small business loans.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.